FREE 12-PAGE REPORT

The New Vaccine Growth Model

See where vaccine growth is moving next, from mRNA and cancer vaccines to manufacturing capacity.

Vaccine growth is becoming more uneven, with mRNA, cancer vaccines and contract manufacturing outpacing the wider market. Visiongain’s new briefing compares four markets through 2036 and shows where growth is strongest and what could hold it back.

Inside the Report:

➤ Which vaccine markets are growing fastest through 2036

➤ Where mRNA is finding growth beyond COVID

➤ How cancer vaccines could reshape the commercial model

➤ Where manufacturing and CDMO capacity could limit growth